Works matching IS 10584838 AND DT 2023 AND VI 77 AND IP 7


Results: 27
    1
    2

    In the Literature.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. i, doi. 10.1093/cid/ciad441
    By:
    • Deresinski, Stanley C
    Publication type:
    Article
    3
    4

    Reply to Crawford and Biere-Rafi et al.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 1075, doi. 10.1093/cid/ciad398
    By:
    • Kuut, Tanja A;
    • Müller, Fabiola;
    • Nieuwkerk, Pythia;
    • Rovers, Chantal P;
    • Knoop, Hans
    Publication type:
    Article
    6

    Reply to Acuña-Villaorduña et al.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 1072, doi. 10.1093/cid/ciad376
    By:
    • Williams, Caroline M;
    • Barer, Michael R;
    • Sutherland, Jayne S;
    • Haldar, Pranabashis
    Publication type:
    Article
    7
    8

    Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 950, doi. 10.1093/cid/ciad368
    By:
    • Upasani, Vinit;
    • Townsend, Katie;
    • Wu, Mary Y;
    • Carr, Edward J;
    • Hobbs, Agnieszka;
    • Dowgier, Giulia;
    • Ragno, Martina;
    • Herman, Lou S;
    • Sharma, Sonal;
    • Shah, Devesh;
    • Lee, Simon F K;
    • Chauhan, Neil;
    • Glanville, Julie M;
    • Neave, Lucy;
    • Hanson, Steven;
    • Ravichandran, Sriram;
    • Tynan, Aoife;
    • O'Sullivan, Mary;
    • Moreira, Fernando;
    • Workman, Sarita
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 941, doi. 10.1093/cid/ciad342
    By:
    • Jilg, Nikolaus;
    • Chew, Kara W;
    • Giganti, Mark J;
    • Daar, Eric S;
    • Wohl, David A;
    • Javan, Arzhang Cyrus;
    • Kantor, Amy;
    • Moser, Carlee;
    • Coombs, Robert W;
    • Neytman, Gene;
    • Hoover, Keila;
    • Jana, Atasi;
    • Hart, Phil A;
    • Greninger, Alexander L;
    • Szurgot, Bob;
    • Eron, Joseph J;
    • Currier, Judith S;
    • Hughes, Michael D;
    • Smith, Davey M;
    • Li, Jonathan Z
    Publication type:
    Article
    15

    Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 1012, doi. 10.1093/cid/ciad366
    By:
    • West, Emily;
    • Zeeb, Marius;
    • Grube, Christina;
    • Kuster, Herbert;
    • Wanner, Katrin;
    • Scheier, Thomas;
    • Neumann, Kathrin;
    • Jörimann, Lisa;
    • Hampel, Benjamin;
    • Metzner, Karin J;
    • Kouyos, Roger D;
    • Braun, Dominique L;
    • Günthard, Huldrych F
    Publication type:
    Article
    16
    17
    18

    Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 976, doi. 10.1093/cid/ciad321
    By:
    • Coussement, Julien;
    • Heath, Christopher H;
    • Roberts, Matthew B;
    • Lane, Rebekah J;
    • Spelman, Tim;
    • Smibert, Olivia C;
    • Longhitano, Anthony;
    • Morrissey, Orla;
    • Nield, Blake;
    • Tripathy, Monica;
    • Davis, Joshua S;
    • Kennedy, Karina J;
    • Lynar, Sarah A;
    • Crawford, Lucy C;
    • Crawford, Simeon J;
    • Smith, Benjamin J;
    • Gador-Whyte, Andrew P;
    • Haywood, Rose;
    • Mahony, Andrew A;
    • Howard, Julia C
    Publication type:
    Article
    19
    20
    21

    Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 1053, doi. 10.1093/cid/ciad312
    By:
    • Haley, Connie A;
    • Schechter, Marcos C;
    • Ashkin, David;
    • Peloquin, Charles A;
    • Cegielski, J Peter;
    • Andrino, Barbara B;
    • Burgos, Marcos;
    • Caloia, Lori A;
    • Chen, Lisa;
    • Colon-Semidey, Angel;
    • DeSilva, Malini B;
    • Dhanireddy, Shireesha;
    • Dorman, Susan E;
    • Dworkin, Felicia F;
    • Hammond-Epstein, Heidi;
    • Easton, Alice V;
    • Gaensbauer, James T;
    • Ghassemieh, Bijan;
    • Gomez, Maria E;
    • Horne, David
    Publication type:
    Article
    22

    Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 1023, doi. 10.1093/cid/ciad308
    By:
    • Lo, Carson K L;
    • Komorowski, Adam S;
    • Hall, Clayton W;
    • Sandstrom, Teslin S;
    • Alamer, Amnah A M;
    • Mourad, Omar;
    • Li, Xena X;
    • Ohaly, Rand Al;
    • Benoit, Marie-Ève;
    • Duncan, D Brody;
    • Fuller, Charlotte A;
    • Shaw, Shazeema;
    • Suresh, Mallika;
    • Smaill, Fiona;
    • Kapoor, Andrew K;
    • Smieja, Marek;
    • Mertz, Dominik;
    • Bai, Anthony D;
    • Group, for the McMaster Infectious Diseases Fellow Research
    Publication type:
    Article
    23
    24
    25

    Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 991, doi. 10.1093/cid/ciad297
    By:
    • Sempere, Abiu;
    • Assoumou, Lambert;
    • González-Cordón, Ana;
    • Waters, Laura;
    • Rusconi, Stefano;
    • Domingo, Pere;
    • Gompels, Mark;
    • Wit, Stephane de;
    • Raffi, François;
    • Stephan, Christoph;
    • Masiá, Mar;
    • Rockstroh, Jürgen;
    • Katlama, Christine;
    • Behrens, Georg M N;
    • Moyle, Graeme;
    • Johnson, Margaret;
    • Fox, Julie;
    • Stellbrink, Hans-Jürgen;
    • Guaraldi, Giovanni;
    • Florence, Eric
    Publication type:
    Article
    26
    27

    Orbital Cavity Infestation.

    Published in:
    2023
    By:
    • Silva-Ramos, Carlos Ramiro;
    • Zúñiga, Abraham Katime;
    • Castillo-Lobo, Edinson E;
    • Cortés-Vecino, Jesús A;
    • Faccini-Martínez, Álvaro A
    Publication type:
    Case Study